Frontiers in Pharmacology (Jul 2022)

Commentary: Pharmacological Validation of ASIC1a as a Druggable Target for Neuroprotection in Cerebral Ischemia Using an Intravenously Available Small Molecule Inhibitor

  • Shreya Majagi,
  • Sharan Mangat,
  • Xiang-Ping Chu

DOI
https://doi.org/10.3389/fphar.2022.938748
Journal volume & issue
Vol. 13

Abstract

Read online

No abstracts available.

Keywords